Good results, key is also that no resistance has been detected...

Good results, key is also that no resistance has been detected as remeber, company has always stated that ATC is aimed at 2nd line therapy where resistance to 3TC appears.

Remeber $340M if a takeover at $0.40 is only about 8-9 months of sales based on $550M annual sales. I suggest a takeover of greater than $0.40c would need to be on offer.

Personally, I would prefer a partnership deal double first with Tibotec. get the SP up to $0.50-$0.60c and then wait and see if any buyers want to play the game.

Further Tibotec announcement due by end next week at the latest I would expect